These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5444557)

  • 1. Failure to detect an effect of bilateral nephrectomy (NPX) upon parathyroid hormone (PTH) levels in azotemic human subjects.
    Hattner RS; Johnson JW; Bernstein DS; Hampers CL
    J Clin Endocrinol Metab; 1970 May; 30(5):677-9. PubMed ID: 5444557
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of bromocriptine on serum PTH, calcium and phosphate levels in azotemic rats.
    Elias AN; Vaziri ND; Deftos LJ; Shinto R; Valenta LJ
    Gen Pharmacol; 1985; 16(1):75-7. PubMed ID: 3979799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to show a correlation between serum parathyroid hormone, nerve conduction velocity and serum lipids in hemodialysis patients.
    Schaefer K; Offermann G; von Herrath D; Schröter R; Stölzel R; Arntz HR
    Clin Nephrol; 1980 Aug; 14(2):81-8. PubMed ID: 7408260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of endothelin receptor antagonist on parathyroid gland growth, PTH values and cell proliferation in azotemic rats.
    Jara A; von Höveling A; Jara X; Burgos ME; Valdivieso A; Mezzano S; Felsenfeld AJ
    Nephrol Dial Transplant; 2006 Apr; 21(4):917-23. PubMed ID: 16431896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E; Canaff L; Fox J; Hendy GN
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute responses of parathyroid hormone and 1,25 dihydroxyvitamin D3 to unilateral nephrectomy in healthy donors.
    Lucas PA; Brown RC; Woodhead JS
    Nephrol Dial Transplant; 1986; 1(3):199-203. PubMed ID: 3110674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies on parathyroid hormone resistance of the skeleton in kidney insufficiency].
    Malluche HH; Ritz E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1302-5. PubMed ID: 611839
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
    Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
    Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D
    G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactive parathyroid hormone in early and advanced renal failure.
    von Lilienfeld-Toal H; Gerlach I; Klehr HU; Issa S; Keck E
    Nephron; 1982; 31(2):116-22. PubMed ID: 7121653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients.
    Meakins JL; Milne CA; Hollomby DJ; Goltzman D
    Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocalcemia following bilateral nephrectomy.
    Cheigh JS; Rubin AL; Stenzel KH; Whitsell JC
    Urology; 1973 Aug; 2(2):121-4. PubMed ID: 4769514
    [No Abstract]   [Full Text] [Related]  

  • 14. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
    Roof BS; Piel CF; Gordan GS
    Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of body composition by neutron activation analysis in patient with renal failure.
    Cohn SH; Cinque TJ; Dombrowski CS; Letteri JM
    J Lab Clin Med; 1972 Jun; 79(6):978-94. PubMed ID: 4623613
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of lowering the serum phosphate on parathyroid hormone secretion and total serum calcium during regular hemodialysis.
    Hill AV; Thein-Than ; Cook DB; Derr KN; Latner AL
    Clin Nephrol; 1973; 1(5):284-9. PubMed ID: 4797465
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced calcium absorption after nephrectomy in uremic patients.
    Oettinger CW; Merrill R; Blanton T; Briggs W
    N Engl J Med; 1974 Aug; 291(9):458-60. PubMed ID: 4367269
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum parathyroid hormone concentration in chronic renal failure patients on maintenance haemodialysis.
    Wills MR; Fairney A; Varghese Z; Tatler GL; Baillod RA; Moorhead JF
    Clin Chim Acta; 1974 Nov; 57(1):83-9. PubMed ID: 4430145
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effects of dialysis with cuprophan versus polyacrylonitrile membranes on plasma immunoreactive parathyroid hormone levels in patients on chronic hemodialysis.
    Gueris J; Fournier A; Sebert JL; De Fremont JF; Ferriere C; Covoet B; Quichaud J
    Calcif Tissue Res; 1977 May; 22 Suppl():434-8. PubMed ID: 912564
    [No Abstract]   [Full Text] [Related]  

  • 20. Can calcium, phosphate, calcium phosphate product and intact parathyroid hormone levels be appropriately controlled in dialysis patients?
    Deger SM; Mutluay R; Derici U; Mandiralioglu F; Arinsoy T; Sindel S
    Med Princ Pract; 2011; 20(1):85-9. PubMed ID: 21160221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.